Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A - Science
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A Science
'Horrible' weeks ahead as India's virus catastrophe worsens - The Associated Press
'Horrible' weeks ahead as India's virus catastrophe worsens The Associated Press
Comments
Post a Comment